| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B | $4.0B | $4.1B | $4.0B | $3.5B | $0.8B | $0.7B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | $0.3B | $0.3B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.7B | $0.8B | $0.7B | $0.7B | $0.6B | $0.5B | $0.5B | $0.4B |
| Operating Income | $0.0B | $0.2B | $0.6B | $0.7B | $0.6B | $0.1B | $0.1B | $0.1B |
| Net Income | $-0.1B | $0.0B | $0.5B | $0.5B | $0.4B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $-2.91 | $0.20 | $9.27 | $9.57 | $7.77 | $2.88 | $1.64 | $1.24 |
| EPS (Diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $2.81 | $1.61 | $1.21 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.1B | $7.5B | $8.2B | $7.6B | $7.0B | $5.5B | $4.7B | $3.9B |
| Current Assets | $1.4B | $1.4B | $1.6B | $1.4B | $1.3B | $1.2B | $1.0B | $0.9B |
| Cash & Equivalents | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Total Liabilities | $3.9B | $4.0B | $4.5B | $4.6B | $4.4B | $3.3B | $3.0B | $2.5B |
| Current Liabilities | $1.1B | $1.0B | $1.1B | $1.1B | $1.0B | $0.8B | $0.7B | $0.6B |
| Stockholders' Equity | $3.2B | $3.5B | $3.6B | $3.0B | $2.5B | $2.1B | $1.6B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.7B | $0.7B | $0.6B | $0.8B | — | — | $0.4B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.6B | $-0.6B | $-1.4B | $-0.6B | $-0.7B | $-1.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.5B | $-0.6B | $-0.1B | $-0.0B | $0.7B | $0.0B | $0.2B | $0.6B |